ACRX - AcelRx Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $53.5. This is a potential upside of $52.18 (3953.03%) from yesterday's end of day stock price of $1.32.

AcelRx Pharmaceuticals's activity chart (see below) currently has 12 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 55.83 days.

Most recent stock forecast was given by BRANDON FOLKES from CANTOR FITZGERALD on 01-Dec-2021. First documented stock forecast 16-Apr-2014.

Best performing analysts who are covering ACRX - AcelRx Pharmaceuticals:

Evan Seigerman Randall Stanicky Michael Higgins Biren Amin Hugo Ong Brandon Folkes

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



2 years 2 months 22 days ago

0/1 (0%)

$74.6 (87.35%)



$15.38 (1260.66%)


3 years 3 months 17 days ago

4/4 (100%)

$-12.4 (-42.76%)




$118.78 (9736.07%)

4 years 9 months 14 days ago

0/1 (0%)

$56.4 (88.68%)



$198.78 (16293.44%)


5 years 3 months 21 days ago

0/2 (0%)

$104 (108.33%)


5 years 4 months 8 days ago

0/2 (0%)

$27.1 (29.17%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACRX (AcelRx Pharmaceuticals) average time for price targets to be met?

On average it took 55.83 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on ACRX (AcelRx Pharmaceuticals) with a proven track record?


Which analyst has the current lower performing score on ACRX (AcelRx Pharmaceuticals) with a proven track record?


Which analyst has the most public recommendations on ACRX (AcelRx Pharmaceuticals)?

Evan Seigerman works at BMO and has 2 price targets and 2 ratings on ACRX

Which analyst is the currently most bullish on ACRX (AcelRx Pharmaceuticals)?

Michael Higgins with highest potential upside - $198.78

Which analyst is the currently most reserved on ACRX (AcelRx Pharmaceuticals)?

Biren Amin with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?